TLR7 agonist Imiquimod reduces the negative regulatory function of IL-10 transfected mouse bone marrow-derived dendritic cells
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To observe the effects of TLR7 agonist on the immune function of IL-10 transfected bone-marrow derived dendritic cell(mDC). Methods:The IL-10 plasmid was transfected to mouse mDC,and TLR7 agonist,Imiquimod,was added to mDC for 48 h. The expression of MHCⅡ,CD80,CD86,FasL in mDC were detected with flow cytometry,and the production of the IL-6 and TNF-α was detemined by ELISA. Results:IL-10 suppressed the expression of MHCⅡ,CD80,CD86,decreased the production of IL-6 and TNF-α,and increased the expression of FasL on mDC. Imiquimod increased the expression of MHCⅡ,CD80 and CD86,which enhanced the production of IL-6 and TNF-α,but inhibited of FasL expression by the IL-10 transfected mDC. Conclusion:TLR7 activation reverses IL-10 induced low response of mDC.

    Reference
    Related
    Cited by
Get Citation

弓 莉,王元占,卢 涛,白晓燕,朱玉峰,吴湘慧. TLR7激动剂Imiquimod减弱转染IL-10的小鼠髓样树突状细胞的负向调节功能[J].南京医科大学学报(自然科学版英文版),2015,(10):1360-1363.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 01,2013
  • Revised:
  • Adopted:
  • Online: October 28,2015
  • Published:
Article QR Code